TestPage MDR
From GxPlex
This is the approved revision of this page, as well as being the most recent.
| Document Information | |
|---|---|
| Area of validity | EU |
| Scope(s) | MD |
| Document type | Regulation |
| Document name | Medical Device Regulation (EU) 2017/745 |
| Version / Revision | 2017/745, amended by 2023/607 |
| Official source | Official link |
| Language(s) | EN, DE, FR (all EU official languages) |
| Status | Current |
| Restricted access | No |
The Medical Device Regulation (MDR) 2017/745 replaces the former Medical Device Directive (MDD 93/42/EEC) and the Active Implantable Medical Device Directive (AIMDD 90/385/EEC). It establishes a uniform regulatory framework for medical devices across EU member states, with a strong focus on clinical evidence, post-market surveillance, and traceability.
Full application started on 26 May 2021. The amendment 2023/607 introduced a phased transition period for legacy devices.
Key references
| Topic / Keyword(s) | Category / Chapter | Scope | Linked document | Description |
|---|---|---|---|---|
| Post-market surveillance, PMCF | Clinical | MD | MDR 2017/745 – Articles 83–86 & Annex XIV Part B: Post-Market Surveillance and PMCF | Articles 83–86 define the mandatory PMS system; Annex XIV Part B specifies PMCF requirements. |
| Unique Device Identification, UDI, Traceability | Labelling | MD | MDR 2017/745 – Articles 27–29 & Annex VI: Unique Device Identification (UDI) | Articles 27–29 and Annex VI establish the UDI system. All devices must carry a UDI carrier on label and packaging. |
| Clinical evaluation, Clinical evidence | Clinical | MD | Article 61 and Annex XIV Part A define the clinical evaluation process and documentation requirements (CER). Page not yet created. |
Related documents
- In Vitro Diagnostic Medical Devices Regulation (EU) 2017/746 – Parallel regulation for IVDs
Rate this page
